Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein

M G Cusi1, S Fischer, R Sedlmeier

  • 1Department of Molecular Biology, Section of Microbiology, University of Siena, Via Laterina, 8-53100, Siena, Italy. cusi@unisi.it

Virus Research
|February 28, 2001
PubMed

Insights

Researchers identified a specific mumps virus protein fragment (HN3) that elicits neutralizing antibodies. A smaller peptide from this fragment induced antibodies against wild-type mumps but not the Urabe Am9 vaccine, suggesting a critical new epitope for immune response.

Area of Science:

  • Virology and Immunology
  • Molecular Biology

Background:

  • The hemagglutinin-neuraminidase (HN) protein of mumps virus is crucial for viral infectivity and is a target for immune responses.
  • Understanding specific epitopes on the HN protein is essential for developing effective vaccines and antiviral therapies against mumps virus.

Purpose of the Study:

  • To identify immunogenic fragments of the mumps virus hemagglutinin-neuraminidase (HN) protein capable of inducing neutralizing antibodies.
  • To investigate a specific peptide epitope within the HN protein for its potential role in eliciting protective humoral immunity against mumps virus.

Main Methods:

  • Expression of four full-length hemagglutinin-neuraminidase (HN) protein fragments in HeLa cells.
  • Immunization of mice with cell extracts containing HN fragments and a synthetic peptide derived from HN3.
  • Assays to measure hemagglutination-inhibiting and neutralizing antibody production against mumps wild-type and Urabe Am9 vaccine viruses.

Main Results:

  • Fragment HN3 (amino acids 213-372) successfully induced hemagglutination-inhibiting and neutralizing antibodies.
  • A synthetic peptide (NSTLGVKSAREF, amino acids 329-340) from HN3 elicited antibodies against wild-type mumps virus.
  • Antibodies generated by the synthetic peptide did not neutralize the Urabe Am9 vaccine strain of mumps virus.

Conclusions:

  • The HN3 fragment contains immunogenic regions capable of stimulating a humoral immune response against mumps virus.
  • The synthetic peptide NSTLGVKSAREF may represent a novel epitope critical for protective immunity.
  • This epitope's differential reactivity suggests potential for targeted vaccine development or distinguishing between wild-type and vaccine-induced immunity.